Industry needs more time to draft comments on FDA’s proposed rule to establish a final OTC sunscreen drug monograph and likely will request rulemaking deferrals for at least some of the 12 sunscreen active ingredients that, according to FDA, require additional data to show general recognition of safety and effectiveness.
The Personal Care Products Council and Consumer Healthcare Products Association submitted a joint request to the agency March 4 seeking an extended opportunity to comment on the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?